Home » ROCHE DIAGNOSTICS AMPLICHIP CYP450 TEST NOW AVAILABLE FROM LABCORP
ROCHE DIAGNOSTICS AMPLICHIP CYP450 TEST NOW AVAILABLE FROM LABCORP
Laboratory Corporation of America Holdings (LabCorp) recently announced the
availability of Roche Diagnostics' Cytochrome AmpliChip P450 2D6/2C19 Genotyping
and Phenotyping Assay as an enhancement to LabCorp's growing pharmacogenetics
test menu. Cleared by the U.S. Food and Drug Administration for diagnostic use,
the assay utilizes DNA microarray technology to provide a rapid method of identifying
multiple genetic variants in two cytochrome P450 (CYP450) genes, CYP2D6 and
CYP2C19.
Yahoo
News
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May